These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2201465)

  • 21. The use of exploratory analyses within the National Institute for Health and Care Excellence single technology appraisal process: an evaluation and qualitative analysis.
    Kaltenthaler E; Carroll C; Hill-McManus D; Scope A; Holmes M; Rice S; Rose M; Tappenden P; Woolacott N
    Health Technol Assess; 2016 Apr; 20(26):1-48. PubMed ID: 27049841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets.
    Brixner D; Maniadakis N; Kaló Z; Hu S; Shen J; Wijaya K
    Value Health Reg Issues; 2017 Sep; 13():1-6. PubMed ID: 29073981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Technology assessment: approach and reimbursement.
    Yaszemski MJ; Polly DW; Boden SD; Andersson GB
    Spine (Phila Pa 1976); 2007 May; 32(11 Suppl):S39-43. PubMed ID: 17495585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A model for technology assessment applied to pulse oximetry. The Technology Assessment Task Force of the Society of Critical Care Medicine.
    Crit Care Med; 1993 Apr; 21(4):615-24. PubMed ID: 8472583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reimbursement programs and health technology assessment for diabetes devices and supplies: a Canadian perspective.
    Cheung RY; Mui V
    J Diabetes Sci Technol; 2015 May; 9(3):706-10. PubMed ID: 25697719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noninvasive blood gas monitoring: a review for use in the adult critical care unit. Technology Subcommittee of the Working Group on Critical Care, Ontario Ministry of Health.
    CMAJ; 1992 Mar; 146(5):703-12. PubMed ID: 1562943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health technology assessment and economic evaluation across jurisdictions.
    Simoens S
    Value Health; 2010; 13(6):857-9. PubMed ID: 20701730
    [No Abstract]   [Full Text] [Related]  

  • 28. Computers enlisted in critical care.
    Morrissey J
    Mod Healthc; 1993 Sep; 23(39):64. PubMed ID: 10128486
    [No Abstract]   [Full Text] [Related]  

  • 29. Health technology assessment and personalized medicine: are economic evaluation guidelines sufficient to support decision making?
    Husereau D; Marshall DA; Levy AR; Peacock S; Hoch JS
    Int J Technol Assess Health Care; 2014 Apr; 30(2):179-87. PubMed ID: 24806420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical care medicine in the United States: what we know, what we do not, and where we go from here.
    Cohen NH
    Crit Care Med; 2010 Jan; 38(1):304-6. PubMed ID: 20023473
    [No Abstract]   [Full Text] [Related]  

  • 31. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.
    Laupacis A; Feeny D; Detsky AS; Tugwell PX
    CMAJ; 1992 Feb; 146(4):473-81. PubMed ID: 1306034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The iatrogenic-harm cost equation and new technology.
    Webster CS
    Anaesthesia; 2005 Sep; 60(9):843-6. PubMed ID: 16115243
    [No Abstract]   [Full Text] [Related]  

  • 33. Cost escalation in health-care technology--possible solutions.
    Járos GG; Boonzaier DA
    S Afr Med J; 1993 Jun; 83(6):420-2. PubMed ID: 8211460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The need for economic evaluation of telemedicine to evolve: the experience in Alberta, Canada.
    Hailey D; Jennett P
    Telemed J E Health; 2004; 10(1):71-6. PubMed ID: 15104918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical technology assessment--intended for whom?
    Mariner WK
    Am J Public Health; 1993 Nov; 83(11):1525-6. PubMed ID: 8238670
    [No Abstract]   [Full Text] [Related]  

  • 36. [Accreditation in a health technology assessment perspective].
    Moth G; Stabel HH; Kudsk AZ; Hansen L; Rask MT; Mainz J
    Ugeskr Laeger; 2004 May; 166(19):1800-2. PubMed ID: 15174432
    [No Abstract]   [Full Text] [Related]  

  • 37. Technology planning: benefit analysis.
    Johnson MD; Morrison M
    Hosp Technol Ser; 1995 Oct; 14(12):9-11. PubMed ID: 10152543
    [No Abstract]   [Full Text] [Related]  

  • 38. Cost modeling to justify technology acquisitions.
    Vanden Brink J; Gray S
    Healthc Financ Manage; 1997 Jun; 51(6):72-6. PubMed ID: 10167845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experiences with and impact of health technology assessment on the German Standing Committee of physicians and patients].
    Gibis B; Rheinberger P
    Z Arztl Fortbild Qualitatssich; 2002 Feb; 96(2):82-90. PubMed ID: 11921610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AHRQ's free research can help plans anticipate coverage issues.
    Roberts DC; Schoelles K
    Manag Care; 2013 Oct; 22(10):41-4. PubMed ID: 24344527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.